biotech companies

5 statements across 2 episodes · 3 bullish · 0 bearish · 2 people on the record · first statement Sep 13, 2017 by Elizabeth Iorns · across every show →

Everything said about biotech companies, oldest first

Sep 13, 2017 neutral
Insight
Iorns: Biotech Startups Face Tech Risk Rather Than Market Demand Uncertainty
“I think one of the interesting differences between biotech companies and sort of software, just tech companies is that the actual market, there's not really that, that question. Like if you're a biotech company and you're going to cure Alzheimer's disease, the…”
Elizabeth Iorns Sep 13, 2017 ▶ 5:42 Elizabeth Iorns on Biotech Companies in YC · Y Combinator
Sep 13, 2017 positive
Insight
Iorns: YC Biotechs Advance Market Understanding Rather Than Lab Experiments
“So they may not make, you know, a really significant advancement in terms of the experimental work, but they certainly will make a significant advancement in terms of understanding the market and understanding what steps are required To get to the market in a …”
Elizabeth Iorns Sep 13, 2017 ▶ 3:54 Elizabeth Iorns on Biotech Companies in YC · Y Combinator
Sep 13, 2017 positive
Assertion Not checkable as stated
Iorns: YC Biotechs Get Rapid Results by Outsourcing Lab Studies
“So if they can outsource those experiments, then they'll often be able to get results quickly, and we have had a lot of success with that with our biotech companies where they've actually worked with external companies that are already up and running to do, fo…”
Elizabeth Iorns Sep 13, 2017 ▶ 4:36 Elizabeth Iorns on Biotech Companies in YC · Y Combinator
Oct 3, 2018 positive
Assertion Contradicted
Cheung: Y Combinator has backed hundreds of biotech companies by 2018
“She's also a part-time partner at YC, which means in her free time, she helps all our biotech companies at which, at this point it's like hundreds, I don't know what the exact number is, but hundreds of biotech companies.”
Adora Cheung Oct 3, 2018 ▶ 0:54 A Conversation with Elizabeth Iorns - Advice for Biotech Founders · Y Combinator
Oct 3, 2018 neutral
Assertion Supported
Iorns: Most therapeutic biotech startups never bring an approved product to market
“For a biotech company that's in the therapeutic space, you know, really you're not going to have any commercial revenue until you have an approved product that is sold on the market, which actually most biotechs never have.”
Elizabeth Iorns Oct 3, 2018 ▶ 31:35 A Conversation with Elizabeth Iorns - Advice for Biotech Founders · Y Combinator
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 300 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.